Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times : Clinical practice- based expert opinion
Copyright © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved..
BACKGROUND AND AIMS: The ongoing pandemic of coronavirus disease 2019 (COVID-19) is rapidly evolving, thereby posing a profound challenge to the global healthcare system. Cardiometabolic disorders are associated with poor clinical outcomes in persons with COVID-19. Healthcare challenges during the COVID-19 pandemic are linked to resource constraints including shortage of Personal Protective Equipment's (PPE), laboratory tests and medication. In this context, a group of clinical experts discussed the endocrine and cardiology vigilance required in times of COVID-19. Further, the group proposed certain resource husbandry recommendations to be followed during the pandemic to overcome the constraints.
METHOD: The clinical experts discussed and provided their inputs virtually. The expert panel included clinical experts comprising endocrinologists, Consultant Physicians and cardiologists from India. The panel thoroughly reviewed existing literature on the subject and proposed expert opinion.
RESULTS: The expert panel put forward clinical practice-based opinion for the management of cardiometabolic conditions including diabetes mellitus and hypertension. As these conditions are associated with poor clinical outcomes, the expert panel recommends that these persons be extra-cautious and take necessary precautions during the ongoing pandemic. Further, experts also provided appropriate, affordable, available and accessible solution to the resource constraint situations in times of COVID-19 pandemic.
CONCLUSION: The clinical expert opinion put forward in this article will serve as a reference for clinicians treating diabetes and cardiovascular disease during the COVID-19 pandemic.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Diabetes & metabolic syndrome - 15(2021), 1 vom: 01. Jan., Seite 55-62 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Das, Ashok Kumar [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Blood Glucose |
|---|
| Anmerkungen: |
Date Completed 11.03.2021 Date Revised 07.08.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.dsx.2020.11.014 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM318754827 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM318754827 | ||
| 003 | DE-627 | ||
| 005 | 20231225170021.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.dsx.2020.11.014 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1062.xml |
| 035 | |a (DE-627)NLM318754827 | ||
| 035 | |a (NLM)33310177 | ||
| 035 | |a (PII)S1871-4021(20)30479-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Das, Ashok Kumar |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times |b Clinical practice- based expert opinion |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.03.2021 | ||
| 500 | |a Date Revised 07.08.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved. | ||
| 520 | |a BACKGROUND AND AIMS: The ongoing pandemic of coronavirus disease 2019 (COVID-19) is rapidly evolving, thereby posing a profound challenge to the global healthcare system. Cardiometabolic disorders are associated with poor clinical outcomes in persons with COVID-19. Healthcare challenges during the COVID-19 pandemic are linked to resource constraints including shortage of Personal Protective Equipment's (PPE), laboratory tests and medication. In this context, a group of clinical experts discussed the endocrine and cardiology vigilance required in times of COVID-19. Further, the group proposed certain resource husbandry recommendations to be followed during the pandemic to overcome the constraints | ||
| 520 | |a METHOD: The clinical experts discussed and provided their inputs virtually. The expert panel included clinical experts comprising endocrinologists, Consultant Physicians and cardiologists from India. The panel thoroughly reviewed existing literature on the subject and proposed expert opinion | ||
| 520 | |a RESULTS: The expert panel put forward clinical practice-based opinion for the management of cardiometabolic conditions including diabetes mellitus and hypertension. As these conditions are associated with poor clinical outcomes, the expert panel recommends that these persons be extra-cautious and take necessary precautions during the ongoing pandemic. Further, experts also provided appropriate, affordable, available and accessible solution to the resource constraint situations in times of COVID-19 pandemic | ||
| 520 | |a CONCLUSION: The clinical expert opinion put forward in this article will serve as a reference for clinicians treating diabetes and cardiovascular disease during the COVID-19 pandemic | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a COVID-19 resource husbandry | |
| 650 | 4 | |a Cardiometabolic vigilance | |
| 650 | 4 | |a Diabetes mellitus | |
| 650 | 4 | |a Hypertension | |
| 650 | 7 | |a Blood Glucose |2 NLM | |
| 650 | 7 | |a Cardiotonic Agents |2 NLM | |
| 650 | 7 | |a Hypoglycemic Agents |2 NLM | |
| 700 | 1 | |a Kalra, Sanjay |e verfasserin |4 aut | |
| 700 | 1 | |a B, Krishnakumar |e verfasserin |4 aut | |
| 700 | 1 | |a Sharma, Kamal |e verfasserin |4 aut | |
| 700 | 1 | |a John, Mathew |e verfasserin |4 aut | |
| 700 | 1 | |a Nair, Tiny |e verfasserin |4 aut | |
| 700 | 1 | |a Shaikh, Shehla |e verfasserin |4 aut | |
| 700 | 1 | |a Khandelwal, Deepak |e verfasserin |4 aut | |
| 700 | 1 | |a Priya, Gagan |e verfasserin |4 aut | |
| 700 | 1 | |a Dutta, Deep |e verfasserin |4 aut | |
| 700 | 1 | |a Gangadhar, Prathosh |e verfasserin |4 aut | |
| 700 | 1 | |a Dhingra, Atul |e verfasserin |4 aut | |
| 700 | 1 | |a Tiwaskar, Mangesh |e verfasserin |4 aut | |
| 700 | 1 | |a Shukla, Rishi |e verfasserin |4 aut | |
| 700 | 1 | |a Das, Sambit |e verfasserin |4 aut | |
| 700 | 1 | |a Baruah, Manash Pratim |e verfasserin |4 aut | |
| 700 | 1 | |a Gangopadhyay, Kalyan Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Ramakrishnan, Santosh |e verfasserin |4 aut | |
| 700 | 1 | |a Deshmukh, Vaishali |e verfasserin |4 aut | |
| 700 | 1 | |a Dasgupta, Arundhati |e verfasserin |4 aut | |
| 700 | 1 | |a Kumar, GVijaya |e verfasserin |4 aut | |
| 700 | 1 | |a Pandey, Neelam |e verfasserin |4 aut | |
| 700 | 1 | |a Joshi, Amya |e verfasserin |4 aut | |
| 700 | 1 | |a Surana, Vineet Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Punyani, Hitesh |e verfasserin |4 aut | |
| 700 | 1 | |a Shah, Parag |e verfasserin |4 aut | |
| 700 | 1 | |a Rattan, Aditya |e verfasserin |4 aut | |
| 700 | 1 | |a Chandrasekaran, Sruti |e verfasserin |4 aut | |
| 700 | 1 | |a Asirwatham, Arthur |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Diabetes & metabolic syndrome |d 2007 |g 15(2021), 1 vom: 01. Jan., Seite 55-62 |w (DE-627)NLM189445564 |x 1878-0334 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2021 |g number:1 |g day:01 |g month:01 |g pages:55-62 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.dsx.2020.11.014 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2021 |e 1 |b 01 |c 01 |h 55-62 | ||